Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
ALPINE IMMUNE SCIENCES INC | 3,813,926 | +1,409,312 | $72,693 |
ALPN | 3,813,926 | +1,409,312 | $72,693 |
CABALETTA BIO INC | 2,110,401 | +4,401 | $47,906 |
CABA | 2,110,401 | +4,401 | $47,906 |
MERUS N V | 1,135,225 | -15,000 | $31,219 |
MRUS | 1,135,225 | -15,000 | $31,219 |
TSCAN THERAPEUTICS INC | 5,224,600 | UNCH | $30,459 |
TCRX | 5,224,600 | UNCH | $30,459 |
C4 THERAPEUTICS INC | 3,134,396 | +2,115,166 | $17,709 |
CCCC | 3,134,396 | +2,115,166 | $17,709 |
STOKE THERAPEUTICS INC | 2,956,918 | +1,246,764 | $15,553 |
STOK | 2,956,918 | +1,246,764 | $15,553 |
AUTOLUS THERAPEUTICS PLC | 1,858,409 | +495,384 | $11,968 |
AUTL | 1,858,409 | +495,384 | $11,968 |
GH RESEARCH PLC | 1,838,617 | +735,439 | $10,664 |
GHRS | 1,838,617 | +735,439 | $10,664 |
KINNATE BIOPHARMA INC | 1,997,006 | UNCH | $4,733 |
KNTE | 1,997,006 | UNCH | $4,733 |
SILENCE THERAPEUTICS PLC | 235,787 | UNCH | $4,096 |
SLN | 235,787 | UNCH | $4,096 |
THESEUS PHARMACEUTICALS INC | 702,415 | UNCH | $2,845 |
THRX | 702,415 | UNCH | $2,845 |
PIERIS PHARMACEUTICALS INC | 9,775,849 | UNCH | $1,779 |
PIRS | 9,775,849 | UNCH | $1,779 |
BIONOMICS LIMITED | 824,305 | +8,793 | $1,220 |
BNOX | 824,305 | +8,793 | $1,220 |
NEKTAR THERAPEUTICS | 1,929,198 | +162,383 | $1,090 |
NKTR | 1,929,198 | +162,383 | $1,090 |
See Full List: All Stocks Held By Lynx1 Capital Management LP
Including:
Biggest exits
Biggest increased positions
Biggest decreased positions
See Details: Top 10 Stocks Held By Lynx1 Capital Management LP
Size ($ in 1000's)
At 12/31/2023: $254,317 At 09/30/2023: $151,185 Combined Holding Report Includes:
Lynx1 Capital Management LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Lynx1 Capital Management LP 13F filings. Link to 13F filings: SEC filings |